When it comes to protecting your eyesight, the world is on the brink

Health care providers are facing an increasing crisis over the issue of retinal degeneration, the most common form of degenerative eye disease.

Many of them are scrambling to find the right drugs, surgeries, and treatments. 

The American Academy of Ophthalmology says that by 2030, about 50 million people will have retinal detachment.

But even in that year, there’s a possibility that this will be even worse. 

“It’s going to be much worse than that,” says Dr. Thomas Gaffney, a former president of the American Academy for Retinal Surgery.

“I think we are looking at the tipping point,” Gaffey told Vice News in an interview.

Gaffney and other experts believe retinal injury is due to a combination of genetics, environmental factors, and a lack of proper treatment. 

We don’t know what the mechanism is, and we don’t understand how the disease develops,” Gafney told Vice. 

Scientists have identified a few things that may be helping retinal deterioration, but they are far from perfect. 

A recent study by the National Institutes of Health looked at more than 100,000 people and found that many of them had degenerative retinal diseases.

One group had degeneration of the cornea and some of the blood vessels that supply it.

Researchers also saw signs of genetic mutations that affected the cells that make blood vessels.”

The most exciting finding is that the genetic mutations are much more prevalent than we thought,” Gaffeey said.”

There’s a genetic component to degenerative vision.

That is a really exciting discovery,” Giffey added.

More than a million Americans now have retinitis pigmentosa, a degenerative disease that can cause blindness, retinal deformities, and even death.

It is the most deadly form of the disease.

According to the Mayo Clinic, about 25% of people with retinopathy will die, but about 90% of those who do die will have some form of permanent damage. 

Retinopathy affects the cells lining the eye, called the retinal pigment epithelium, which makes up a layer of pigment that covers the lens.

It has a large role in vision.

The retina is made of about 70 percent retinal cells, with the remaining 10 percent in the outer layer called the rods. 

What Causes Retinopathy? 

The retina is an amazing part of our vision, but it is a very small part of what makes us who we are.

Scientists don’t have a full understanding of the genetics of retinopathies, but there are a few theories that are being explored. 

Gaffey believes that certain mutations may be linked to retinotoxicity, which means that if the body is not doing its job properly, it is damaging the retina. 

One of these mutations, he says, is one that affects the protein known as the retinoblastoma suppressor protein, or RPSP, which is responsible for protecting the cells.

The protein can be activated by a variety of things, including the sun, UV light, and certain drugs.”RPSP is the keystone protein that helps keep the retina healthy, so if you are having problems protecting it, it may be something that is going on,” Gaskin told Vice in an email.

This is a gene that controls the production of the retinoic acid, the pigment that the eye uses to produce its own light,” GAFNEY said. “

It is thought that this is what is causing the retinas degeneration.

This is a gene that controls the production of the retinoic acid, the pigment that the eye uses to produce its own light,” GAFNEY said.

“There is also a genetic mutation that is causing a protein called RAP, which activates RPS in the body.”RAP causes damage to the retinoschin-3 receptor, which allows the cells in the retina to make more of their own light. 

But this doesn’t explain why retinopathic patients with degenerative eyes also have retinoacne, or how retinotic treatments work in the first place.

Gaffrey thinks that RAP is a critical component of the disorder. 

“[It’s] a very, very important piece of the puzzle,” Gagfey said, adding that if RAP were to get damaged in a way that it wasn’t designed to handle, it could destroy the entire retinal tissue and cause retinal atrophy.

RAP plays a key role in preventing the development of retinoidosis, a rare and serious eye disease that causes retinal damage that leads to blindness.

The disorder causes the retina, the outermost layer of the eye’s cells, to be missing, making the retina more fragile.

Retinal degenerations are also known to be associated with other eye diseases.

In addition to the loss of RPS and the protein, scientists are also investigating whether other proteins are also involved in retinokines, which play a key part